SCHEMBL145307

SCHEMBL145307

O=C(O)N1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16904 1.00 ALDH1A1 (0.42)
SCHEMBL28468317 1.00 ALDH1A1 (0.42)
SCHEMBL9079929 1.00 ALDH1A1 (0.42)
SCHEMBL28497988 0.96 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL10787986 0.96 ALDH1A1 (0.40)
SCHEMBL21809205 0.89 ALDH1A1 (0.55)
SCHEMBL27087746 0.87 ALDH1A1 (0.35)
SCHEMBL76824 0.85
SCHEMBL153114 0.85
SCHEMBL31156371 0.85 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361490-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA CELLVIE AG (CH) 2025-11-27 US claimed
EP-4535996-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA cellvie AG (CH) 2025-04-16 EP claimed
CN-119365073-A Compositions and methods for cryopreserving mitochondria 赛立维公司 2025-01-24 CN claimed
WO-2023237789-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA CELLVIE AG (CH) 2023-12-14 WO claimed
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 EP claimed
EP-2557133-B1 Method for providing PVC structures for adhesive applications ROHM & HAAS (US) 2016-11-16 EP claimed
US-20150080318-A1 Compositions for the Treatment or Prophylaxis of Viral Infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2015-03-19 US claimed
US-8912163-B2 Compositions for the treatment or prophylaxis of viral infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-12-16 US claimed
US-20130338096-A1 Compositions for the Treatment or Prophylaxis of Viral Infections CONSEJO SUPERIOR DE INVESTIGACIONES CEINTIFICAS (ES) 2013-12-19 US claimed
US-8513215-B2 Compositions for the treatment or prophylaxis of viral infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2013-08-20 US claimed
EP-1620130-A1 PRODRUGS CLEAVABLE BY CD26 K.U. Leuven Research & Development (BE) 2006-02-01 EP claimed
WO-2004098644-A1 PRODRUGS CLEAVABLE BY CD26 K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2004-11-18 WO claimed
WO-2004093643-A2 MAGNETICALLY CONTROLLABLE DRUG AND GENE DELIVERY STENTS THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2004-11-04 WO claimed
US-20040171555-A1 Prodrugs of DP IV-inhibitors PROBIODRUG (DE) 2004-09-02 US claimed
US-20020049164-A1 Prodrugs of DP IV-inhibitors PROSIDION LIMITED (GB) 2002-04-25 US claimed
US-20010020006-A1 Compounds of unstable DP IV-inhibitors PROSIDION LIMITED (GB) 2001-09-06 US claimed
CN-1306541-A Compound for unstable dipeptidyl peptidase IV inhibitors PROBIODRUG GES FUR ARZNEIMITTE (DE) 2001-08-01 CN claimed
CN-1306540-A Prodrugs of dipeptidyl peptidase IV inhibitors PROBIODRUG GES FUR ARZNEIMITTE (DE) 2001-08-01 CN claimed
WO-1993011669-A1 USE OF 3-PHENYLURACIL DERIVATIVES FOR THE DESICCATION AND ABSCISSION OF PLANT PARTS BASF AKTIENGESELLSCHAFT (DE) 1993-06-24 WO claimed
EP-0078853-B1 PROCESS FOR PREPARING BETA-CHLOROALANINE MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-11-13 EP claimed